What's happened
The Federal Trade Commission has filed a lawsuit against three major pharmacy benefit managers—CVS Caremark, Cigna's Express Scripts, and UnitedHealth's OptumRx—accusing them of anticompetitive practices that inflate insulin prices for patients. The lawsuit aims to address the rising costs of essential medications for millions of Americans.
Why it matters
What the papers say
According to The New York Times, the FTC's lawsuit targets the three largest PBMs, which control 80% of prescriptions in the U.S. The agency's deputy director, Rahul Rao, stated, 'The largest P.B.M.s have extracted millions of dollars off the backs of patients who need lifesaving medications.' In contrast, CVS Caremark defended its practices, asserting that it protects patients from rising drug prices. Express Scripts has also criticized the FTC's report, claiming it is driven by political motives. This divergence highlights the ongoing debate over the role of PBMs in the healthcare system and their impact on drug affordability.
How we got here
The lawsuit follows a July FTC report criticizing pharmacy benefit managers (PBMs) for manipulating drug prices and harming consumers. PBMs negotiate drug prices and manage formularies for insurers, but their practices have drawn scrutiny for contributing to high out-of-pocket costs for patients.
Common question
-
How Do Pharmacy Benefit Managers Affect Insulin Prices?
The rising costs of insulin have become a pressing issue for many Americans, and the role of pharmacy benefit managers (PBMs) in this crisis is under scrutiny. With the Federal Trade Commission (FTC) filing a lawsuit against major PBMs, it's essential to understand how these entities influence drug pricing and what it means for patients. Below are some common questions regarding this topic.
-
What is the FTC's Role in Regulating Healthcare Costs?
The Federal Trade Commission (FTC) plays a crucial role in regulating healthcare costs, particularly in the context of pharmacy benefit managers (PBMs). Recent actions, including a lawsuit against major PBMs, have raised questions about how these entities influence drug pricing and patient access to essential medications. Below, we explore common questions regarding the FTC's involvement in healthcare regulation and its implications for consumers.
More on these topics
-
The Federal Trade Commission is an independent agency of the United States government whose principal mission is the enforcement of civil U.S. antitrust law and the promotion of consumer protection.
-
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. Eli Lilly, a
-
Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world's fifth-largest by prescription sales.
-
Kamala Devi Harris is an American attorney and politician who has served as the junior United States Senator from California since 2017.
-
CVS Health is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain, CVS Caremark, a pharmacy benefits manager, Aetna, a health insurance provider, among many other brands. The company's headquarter is in Woonsocket, Rhode Island.
-
Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the